Drug-drug interactions in prescriptions of Lorestan province, Western of Iran

Asadbeigi, Mohsen. and Adineh, Ahmad. and Changizian, Sehar. and Bahram, Delfan. and Bahmani, Mahmoud. and Rafieian-Kopaei, Mahmoud. (2015) Drug-drug interactions in prescriptions of Lorestan province, Western of Iran. Journal of Chemical and Pharmaceutical Research (1). pp. 698-700.


Download (86kB) | Preview
Official URL: https://www.scopus.com/inward/record.uri?eid=2-s2....


Rational prescribing means prescribing the more effective and healthiest drug for a disease according to patient’s condition, the type of effective drugs, cost and etc. The non-normative and non-rational prescribing of medicine can cause side effects. Prescribing of effective and safe drugs can have an important role in treatment of patient and the lack of side effect, drug interactions and imposition of additional cost. The aim of this study was to evaluate drug interactions in prescriptions of Lorestan province, western of Iran In this study, at first, the statistic of the insurance prescription of all provincial pharmacies were obtained, interred in the prescription review software of food and drug administration, processed in terms of drug interactions and data were statistically analyzed. This study shows that of the total 1443973 of the prescription numbers, 1112 numbers of that contain 1.25 mg of Digoxin tablets with 40 mg of Furosemide tablets that they have a severe interaction and can lead to arrhythmia in patients. Also 934 prescriptions contain Gemfibrozil and Lovastatin which can lead to myopathy and rhabdomyolysis in consumer patients. The survey revealed that 1.36, 3.76 and 0.56% of prescriptions have mild, moderate and severe interactions, respectively. Existence of severe and moderate drug interactions requires that further workshops be held for physicians on drug interactions.

Item Type: Article
Additional Information: cited By 0
Uncontrolled Keywords: Medicine; Patient treatment, Additional costs; Drug prescriptions; Drug-drug interactions; Food and Drug Administration; Furosemides; Gemfibrozils; Lorestan; Prescribing, Drug interactions, digoxin; furosemide; gemfibrozil; mevinolin, Article; drug interaction; health survey; heart arrhythmia; human; inappropriate prescribing; Iran; myopathy; prescription; rhabdomyolysis
Subjects: QV pharmacology > QV 704 Pharmaceutics
Divisions: Reserach Vice-Chancellar Department > Medical Plants Research Center
Depositing User: Users 1 not found.
Date Deposited: 30 Jul 2017 03:30
Last Modified: 23 Jul 2018 06:13
URI: http://eprints.skums.ac.ir/id/eprint/2019

Actions (login required)

View Item View Item